BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25162299)

  • 1. Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.
    Thomas NE; Kricker A; Waxweiler WT; Dillon PM; Busman KJ; From L; Groben PA; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Orlow I; Paine S; Ollila DW; Reiner AS; Luo L; Hao H; Frank JS; Begg CB; Berwick M;
    JAMA Dermatol; 2014 Dec; 150(12):1306-314. PubMed ID: 25162299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma.
    Vernali S; Waxweiler WT; Dillon PM; Kanetsky PA; Orlow I; Luo L; Busam KJ; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
    JAMA Dermatol; 2017 Oct; 153(10):1026-1031. PubMed ID: 28746718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
    Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
    J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics and prognosis of amelanotic acral melanoma: A comparative study with pigmented acral melanoma.
    Gong HZ; Zheng HY; Li J
    Australas J Dermatol; 2020 Nov; 61(4):358-361. PubMed ID: 32424819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
    Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
    JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
    Thomas NE; Busam KJ; From L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Groben PA; Hao H; Orlow I; Reiner AS; Luo L; Paine S; Ollila DW; Wilcox H; Begg CB; Berwick M
    J Clin Oncol; 2013 Nov; 31(33):4252-9. PubMed ID: 24127443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas.
    Strazzulla LC; Li X; Zhu K; Okhovat JP; Lee SJ; Kim CC
    J Am Acad Dermatol; 2019 May; 80(5):1292-1298. PubMed ID: 30654075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.
    Cheung WL; Patel RR; Leonard A; Firoz B; Meehan SA
    J Cutan Pathol; 2012 Jan; 39(1):33-9. PubMed ID: 22050235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival for patients with single and multiple primary melanomas: the genes, environment, and melanoma study.
    Kricker A; Armstrong BK; Goumas C; Thomas NE; From L; Busam K; Kanetsky PA; Gallagher RP; Marrett LD; Groben PA; Gruber SB; Anton-Culver H; Rosso S; Dwyer T; Berwick M;
    JAMA Dermatol; 2013 Aug; 149(8):921-7. PubMed ID: 23784017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Novo vs Nevus-Associated Melanomas: Differences in Associations With Prognostic Indicators and Survival.
    Cymerman RM; Shao Y; Wang K; Zhang Y; Murzaku EC; Penn LA; Osman I; Polsky D
    J Natl Cancer Inst; 2016 Oct; 108(10):. PubMed ID: 27235387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matched analysis of the prognosis of amelanotic and pigmented melanoma in head and neck.
    Guo W; Yin G; Liu H; Duan H; Huang Z; Chen X
    Acta Otolaryngol; 2020 Sep; 140(9):785-788. PubMed ID: 32449432
    [No Abstract]   [Full Text] [Related]  

  • 12. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
    Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and associations of high-mitotic-rate melanoma.
    Shen S; Wolfe R; McLean CA; Haskett M; Kelly JW
    JAMA Dermatol; 2014 Oct; 150(10):1048-55. PubMed ID: 25142970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of 36 cases of amelanotic melanomas and considerations about the relationship between histologic subtypes and diagnostic delay.
    Gualandri L; Betti R; Crosti C
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):283-7. PubMed ID: 19207640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mucosal melanoma survival in a population-based setting.
    Altieri L; Eguchi M; Peng DH; Cockburn M
    J Am Acad Dermatol; 2019 Jul; 81(1):136-142.e2. PubMed ID: 30296542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and survival of patients with invasive amelanotic melanoma in the USA.
    Moreau JF; Weissfeld JL; Ferris LK
    Melanoma Res; 2013 Oct; 23(5):408-13. PubMed ID: 23883947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
    Dessinioti C; Dimou N; Geller AC; Stergiopoulou A; Lo S; Keim U; Gershenwald JE; Haydu LE; Ribero S; Quaglino P; Puig S; Malvehy J; Kandolf-Sekulovic L; Radevic T; Kaufmann R; Meister L; Nagore E; Traves V; Champsas GG; Plaka M; Dreno B; Varey E; Ramirez DM; Dummer R; Mangana J; Hauschild A; Egberts F; Peris K; Del Regno L; Forsea AM; Zurac SA; Vieira R; Brinca A; Zalaudek I; Deinlein T; Linos E; Evangelou E; Thompson JF; Scolyer RA; Garbe C; Stratigos AJ
    J Natl Cancer Inst; 2019 Dec; 111(12):1314-1322. PubMed ID: 30863861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features.
    Pizzichetta MA; Talamini R; Stanganelli I; Puddu P; Bono R; Argenziano G; Veronesi A; Trevisan G; Rabinovitz H; Soyer HP
    Br J Dermatol; 2004 Jun; 150(6):1117-24. PubMed ID: 15214897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
    Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
    Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anorectal amelanotic melanoma.
    Hillenbrand A; Barth TF; Henne-Bruns D; Formentini A
    Colorectal Dis; 2008 Jul; 10(6):612-5. PubMed ID: 17944970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.